SBIO vs. BTEC
SBIO (ALPS Medical Breakthroughs ETF) and BTEC (Principal Healthcare Innovators Index ETF) are both Health & Biotech Equities funds - SBIO tracks the S-Network Medical Breakthroughs Index while BTEC tracks the NASDAQ U.S. Health Care Innovators Index. Both are passively managed. SBIO charges 0.50%/yr vs 0.42%/yr for BTEC.
Performance
SBIO vs. BTEC - Performance Comparison
Loading charts...
Returns By Period
SBIO
- 1D
- 1.41%
- 1M
- -7.56%
- YTD
- -0.39%
- 6M
- 3.05%
- 1Y
- 65.41%
- 3Y*
- 17.80%
- 5Y*
- 2.68%
- 10Y*
- 8.02%
BTEC
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
SBIO vs. BTEC - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
SBIO ALPS Medical Breakthroughs ETF | 0.06% |
BTEC Principal Healthcare Innovators Index ETF | 0.00% |
SBIO vs. BTEC - Sectors Allocation Comparison
Sectors
SBIO
BTEC
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Financial Services
-
Healthcare
SBIO
BTEC
Basic Materials
SBIO
-
BTEC
-
Communication Services
SBIO
-
BTEC
-
Consumer Cyclical
SBIO
-
BTEC
-
Consumer Defensive
SBIO
-
BTEC
-
Energy
SBIO
-
BTEC
-
Industrials
SBIO
-
BTEC
Real Estate
SBIO
-
BTEC
-
Technology
SBIO
-
BTEC
-
Utilities
SBIO
-
BTEC
-
Financial Services
SBIO
BTEC
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SBIO vs. BTEC — Risk / Return Rank
SBIO
BTEC
SBIO vs. BTEC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ALPS Medical Breakthroughs ETF (SBIO) and Principal Healthcare Innovators Index ETF (BTEC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SBIO | BTEC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.36 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 5.19 | — | — |
| Martin ratioReturn relative to average drawdown | 15.57 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SBIO | BTEC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.24 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.08 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.24 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.21 | — | — |
Drawdowns
SBIO vs. BTEC - Drawdown Comparison
The maximum SBIO drawdown since its inception was -63.06%, which is greater than BTEC's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for SBIO and BTEC.
Loading charts...
Drawdown Indicators
| SBIO | BTEC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.06% | 0.00% | -63.06% |
Max Drawdown (1Y)Largest decline over 1 year | -12.66% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -42.44% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -53.10% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -63.06% | — | — |
Current DrawdownCurrent decline from peak | -16.79% | 0.00% | -16.79% |
Average DrawdownAverage peak-to-trough decline | -28.45% | 0.00% | -28.45% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.22% | — | — |
Volatility
SBIO vs. BTEC - Volatility Comparison
Loading charts...
Volatility by Period
| SBIO | BTEC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.48% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 22.70% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 29.42% | 0.00% | +29.42% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.56% | 0.00% | +33.56% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.17% | 0.00% | +33.17% |
SBIO vs. BTEC - Expense Ratio Comparison
SBIO has a 0.50% expense ratio, which is higher than BTEC's 0.42% expense ratio.
Dividends
SBIO vs. BTEC - Dividend Comparison
Neither SBIO nor BTEC has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
BTEC Principal Healthcare Innovators Index ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% |
Frequently Asked Questions
On fees, BTEC is cheaper at 0.42% per year. The better choice depends on whether you care most about return, fees, risk, or income.
BTEC is cheaper with a 0.42% expense ratio, compared with 0.50% for SBIO.
SBIO and BTEC have nearly identical dividend yields, around 0.00%.
SBIO tracks S-Network Medical Breakthroughs Index, while BTEC tracks NASDAQ U.S. Health Care Innovators Index. They also come from different issuers: SS&C and Principal. Their fees differ too: 0.50% for SBIO and 0.42% for BTEC.
Find the right allocation for SBIO and BTEC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer